Adagene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.

About ADAG

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. 

CEO
Pei Zhi Luo
CEOPei Zhi Luo
Employees
138
Employees138
Headquarters
Suzhou, Jiangsu
HeadquartersSuzhou, Jiangsu
Founded
2011
Founded2011
Employees
138
Employees138

ADAG Key Statistics

Market cap
80.12M
Market cap80.12M
Price-Earnings ratio
-2.64
Price-Earnings ratio-2.64
Dividend yield
Dividend yield
Average volume
49.56K
Average volume49.56K
High today
High today
Low today
Low today
Open price
$1.71
Open price$1.71
Volume
0.00
Volume0.00
52 Week high
$3.16
52 Week high$3.16
52 Week low
$1.33
52 Week low$1.33

Stock Snapshot

The current Adagene(ADAG) stock price is $1.65, with a market capitalization of 80.12M. The stock trades at a price-to-earnings (P/E) ratio of -2.64.

On 2025-11-05, Adagene(ADAG) stock opened at $1.71, reached a high of —, and a low of —.

Adagene(ADAG) shares are trading with a volume of 0, against a daily average of 49.56K.

In the last year, Adagene(ADAG) shares hit a 52-week high of $3.16 and a 52-week low of $1.33.

In the last year, Adagene(ADAG) shares hit a 52-week high of $3.16 and a 52-week low of $1.33.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.